Mtor inhibitor use is associated with a favorable outcome of covid-19 in patients of kidney transplant: results of a retrospective study

HIGHLIGHTS

• who: Biagio Pinchera from the Australian National University, Australia have published the research work: mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study, in the Journal: (JOURNAL) of 11/01/2022
• what: Our real-life study showed a positive impact of therapy with mTOR inhibitors in SARS-CoV-2 infection occurring in patients who underwent kidney transplant.
• how: For each patient the authors evaluated the epidemiological characteristics the laboratory data the data of radiological instrumental investigations clinical characteristics the time . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.